An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

Pei-Shan Yang,1 Chien-Lun Chen,1 Chen-Pang Hou,1 Yu-Hsiang Lin,1 Ke-Hung Tsui1,2 1Department of Urology, 2Prostate Health Laser Center, Chang Gung Memorial Hospital-Linkou, Chang Gung University, College of Medicine, Taipei, Taiwan, Republic of China Purpose: The aim of this study was to investiga...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang PS, Chen CL, Hou CP, Lin YH, Tsui KH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
prostate
neoplasms
α1-adrenergic receptor
LUTS
outcomes
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/dc03241ded0c4ad8b9ee6f6f0f175521
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares